Journal Information

Does the treatment focused on controlling the activity of the underlying inflammatory disease and reducing the serum level of AA protein improve the prognosis of systemic amyloidosis?
V. Barrio, F. Ortiz-Herbener
Nefrologia (English Version). 2008;28 Supl 2:8-9
Is it possible to sustain adequate immunosuppressive efficacy minimizing the nephrotoxicity with a regimen including low doses of calcineurin inhibitors or sirolimus?
S. Jiménez, J. Zamora, A. Muriel, J. Pascual
Nefrologia (English Version). 2008;28 Supl 2:40-1